Brain imaging study for ER+ breast cancer with brain tumors
Part of Brain & nervous system, Cancer, Skin clinical trials.
This trial tests a special PET scan called FES to see if it can detect estrogen receptors in brain metastases. It may help doctors better target treatment for people with ER+ breast cancer that has spread to the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ER+ breast cancer that has spread to the brain (new or returning)
- You are at least 18 years old
- You have stopped certain hormone therapies (like tamoxifen) for at least 8 weeks and others (like fulvestrant) for at least 28 weeks
- You are able to take care of yourself (ECOG score 0 or 1)
- You are expected to live at least 6 more months
- You are already planning to have radiation for your brain tumors
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests a special PET scan (a type of imaging) to look at newly diagnosed ER-positive breast cancer. The goal is to see how well the scan can detect and measure cancer, which may help guide care.
This trial uses a special imaging scan called 18F-FES PET/CT to help doctors plan treatment and check how well it works for breast cancer that is ER-positive (meaning the cancer cells grow in response to estrogen). It may help improve treatment choices and monitoring.
This trial is testing a new type of PET scan (called FAPI) to see if it can help predict how well T-DXd (Enhertu) works on breast cancer that has spread to the brain. Participants will get T-DXd as planned and have the scan before starting treatment.
This trial tests a special PET scan (18F-fluciclovine) to see how well it shows brain metastases after stereotactic radiosurgery (a precise form of radiation). It may help doctors better understand treatment effects.
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
This study tests a new way of using a PET scan to look at brain tumors that have spread from other cancers, before and after focused radiation treatment. The goal is to see if this scan can better predict how well the radiation works.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.